Pentair Announces Agreement to Sell Valves & Controls Business to Emerson

Go back to Pentair Announces Agreement to Sell Valves & Controls Business to Emerson

Buckingham Research Downgrades Emerson (EMR) to Underperform

August 19, 2016 8:03 AM EDT

Buckingham Research downgraded Emerson (NYSE: EMR) from Neutral to Underperform with a price target of $44.00.

For an analyst ratings summary and ratings history on Emerson click here. For more ratings news on Emerson click here.

Shares of Emerson closed at $54.67 yesterday.

... More